Galera Therapeutics is discovering and developing novel mechanism-based therapies that have the potential to improve both treatment and outcomes for patients with cancer.
Learn more about our pipeline, including avasopasem and rucosopasem, our selective dismutase mimetics.
We believe that precisely targeting oxygen metabolic pathways has the potential to offer unique and powerful strategies for treating cancer and addressing treatment-related side effects such as oral mucositis.
Learn More >
The cornerstone of our work is the recognition that oxygen metabolic pathways play important roles in human biology and disease.